Keywords: Novartis, Signifor, GlaxoSMithKline, Raxibacumab, ARIA Pharma, Iclusing, Ponatinib, USA, FDA, Chushing's, Anthrax, Leukemia

US FDA approvals for Signifor, raxibacumab and Iclusig

Article | 17 December 2012

Print This

In a flurry of activity from the US Food and Drug Administration on Friday, the agency – which looks likely ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in